The Life and Legacy of Jimmy Carter
The Daily
12/30/24
•40m
About
Comments
Featured In
In 1976, after the Watergate scandal and the country’s withdrawal from the Vietnam War, American voters elected Jimmy Carter, a Washington outsider who had served one term as governor of Georgia, to the presidency. Mr. Carter brought a new humility to the Oval Office but, by 1980, many Americans had tired of his modest sensibility and chose not to re-elect him. As it would turn out, the qualities that hurt Mr. Carter in the White House formed the foundation of a post-presidential period that helped redefine, and redeem, his legacy in the final decades of his life.
Peter Baker, chief White House correspondent for The New York Times, explains the life, death and legacy of former President Jimmy Carter.
Background reading:
- Read an obituary of Jimmy Carter, whose post-presidency was seen as a model for future commanders in chief.
- Mr. Carter defied the unwritten rule of former presidents: Don’t criticize the occupant of the Oval Office.
- In a never-before-seen interview with The Times, in 2006, Mr. Carter reflected on his life and work as a leader during the Cold War, a Middle East peace broker and his post-presidential career as a citizen diplomat.
For more information on today’s episode, visit nytimes.com/thedaily.
Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.
Previous Episode
For decades, Big Food has been marketing products to people who can’t seem to stop eating, and now, suddenly, they can. The active ingredient in new drugs like Ozempic, Wegovy and Zepbound mimics a natural hormone that slows digestion and signals fullness to the brain.
Around seven million Americans take these drugs, but estimates from Morgan Stanley suggest that number could increase to 24 million within the next decade. More than 100 million American adults are obese, and the drugs may eventually be rolled out to people who don’t have diabetes or obesity, as they seem to tame addictions beyond food — appearing to make cocaine, alcohol and cigarettes more resistible. Research is at an early stage, but the drugs may also cut the risk of stroke, heart and kidney disease, Alzheimer’s and Parkinson’s.
Major food companies are scrambling to research the impact of the drugs on their brands — and figure out how to adjust. But for Mattson, which has invented products for the nation’s biggest food conglomerates for nearly 50 years, the Ozempic threat could be a boon.
Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.
Next Episode
The Year in Books
December 31, 2024
•26m
As 2024 comes to a close, critics, reporters and editors at The New York Times are reflecting on the year in arts and culture, including books.
The deputy editor of Culture and Lifestyle, Melissa Kirsch, speaks with the editor of The New York Times Book Review, Gilbert Cruz, about the best books of 2024 — and of the century. Also, The Times’s book critics detail their favorite reads of the year.
Guest:
- Melissa Kirsch, the deputy editor of Culture and Lifestyle for The New York Times.
- Gilbert Cruz, the editor of The New York Times Book Review.
- M.J. Franklin, an editor for The New York Times Book Review.
- Jennifer Szalai, the nonfiction book critic for The New York Times Book Review.
- A.O. Scott, a critic at large for The New York Times Book Review.
- Sarah Lyall, a writer at large for The Times and the thrillers columnist for The New York Times Book Review.
- Alexandra Jacobs, a critic for The New York Times Book Review.
- Dwight Garner, a critic for The New York Times Book Review.
Background reading:
For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.
Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.
If you like this episode you’ll love
Promoted